NextCure, Inc. Files 8-K on Shareholder Vote Matters

Ticker: NXTC · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1661059

Nextcure, Inc. 8-K Filing Summary
FieldDetail
CompanyNextcure, Inc. (NXTC)
Form Type8-K
Filed DateJun 23, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: shareholder-vote, corporate-governance

Related Tickers: NXTC

TL;DR

NextCure filed an 8-K about a shareholder vote. Details TBD.

AI Summary

NextCure, Inc. filed an 8-K on June 23, 2025, reporting on matters submitted to a vote of security holders as of June 20, 2025. The filing does not contain details on the specific matters voted upon or the outcomes.

Why It Matters

This filing indicates that NextCure, Inc. held a shareholder vote, which could pertain to significant corporate actions or governance changes that may impact the company's future direction.

Risk Assessment

Risk Level: low — The filing is procedural and does not disclose specific financial or operational risks at this time.

Key Players & Entities

  • NextCure, Inc. (company) — Registrant
  • June 20, 2025 (date) — Earliest event reported
  • June 23, 2025 (date) — Date of report
  • Beltsville, Maryland (location) — Principal executive offices

FAQ

What specific matters were submitted to a vote of NextCure, Inc. security holders on or before June 20, 2025?

The filing does not specify the exact matters voted upon, only that such matters were submitted.

What was the outcome of the vote by NextCure, Inc. security holders?

The filing does not disclose the results or outcomes of the shareholder vote.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 20, 2025.

What is the principal business address of NextCure, Inc.?

The principal executive offices are located at 9000 Virginia Manor Road, Suite 200, Beltsville, Maryland 20705.

What is the SEC file number for NextCure, Inc.?

The SEC file number for NextCure, Inc. is 001-38905.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding NextCure, Inc. (NXTC).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.